Skip to main content
. 2017 Feb 1;8(14):23008–23019. doi: 10.18632/oncotarget.14968

Figure 6. MiR-3622b-5p is down-regulated in ERBB2-positive cancer tissues.

Figure 6

The miR-3622b-5p expression was suppressed in a majority of ERBB2-positive breast cancer samples when compared to ERBB2-negative breast cancer samples A. or in a majority of ERBB2-positive gastric cancer samples when compared to ERBB2-negative gastric cancer samples B. The miRNA relative expression levels were normalized to the average value of ERBB2-positive breast cancer samples (A) or ERBB2-positive gastric cancer samples (B).

HHS Vulnerability Disclosure